Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation

Annals of Internal Medicine

Volumn 129, Issue 8, 1998, Pages 643-653

  Mor, Eytan ^a   Kaspa, Ran Tur ^a   Sheiner, Patricia ^b   Schwartz, Myron ^b  

^a RABIN MEDICAL CENTER   (Israel)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING;

EID: 0032532086     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-8-199810150-00013     Document Type: Review

References (94)

1. Tong MJ, el-Farra NS, Reikes AR, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med. 1995;332:1463-6.
2. Castells L, Vargas V, Comas P, Garcia Sureda D, Vidai X, Esteban R, et al. Hepatocellular carcinoma: clinical aspects, diagnosis, and survival in 140 cases. Med Clin (Bare). 1993;100:441-6.
3. Khakoo SI, Grellier LF, Soni PN, Bhattacharya S, Dusheiko GM. Etiology, screening and treatment of hepatocellular carcinoma. Med Clin North Am. 1996;80:1121-45.
4. Colombo M. Hepatocellular carcinoma. J Hepatol. 1992;15:225-36.
5. Di Bisceglie AM, Rustgi VK, Hoofnagle JH, Dusheiko GM, Lotze MT. Hepatocellular carcinoma. Ann Intern Med. 1988;108:390-401.
6. Kang JY, Guan R. Early detection of hepatocellular carcinoma. Digestive Surgery. 1995;12:79-84.
7. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol. 1994;20:65-71.
8. Farmer DG, Rosove MH, Shaked A, Busuttil RW. Current treatment modalities for hepatocellular carcinoma. Ann Surg. 1994;219:236-47.
9. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg. 1991:214:221-8.
10. Ismail T, Angrisani L, Gunson BK, Hubscher SG, Buckels JA, Neuberger JM, et al. Primary hepatic malignancy: the role of liver transplantation. Br J Surg. 1990;77:983-7.
11. Otto G, Heuschen UA, Hofmann WJ, Herfarth C. Primary hepatic malignancy: resection or liver transplantation? Eur J Surg Oncol. 1990;16:346-51.
12. Yamada R, Sato M, Kawabata M, Nakatsuka H, Nakamura K, Takashima S. Hepatic artery embolization in 120 patients with unresectable hepatoma. Radiology. 1983;148:397-401.
13. Livraghi T, Festi D, Monti F, Salmi A, Vetori C. US-guided percutaneous alcohol injection of small hepatic and abdominal tumors. Radiology. 1986; 161:309-12.
14. Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, et al. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg. 1995;1:242-8.
15. Spreafico C, Marchiano A, Regalia E, Frigerio LF, Garbagnati F, Andreola S, et al. Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation. Radiology. 1994;192:687-90.
16. Ikeda K, Saitoh S, Koida I, Arase Y, Tsubota A, Chayama K, et al. A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 patients with viral and alcoholic cirrhosis. Hepatology. 1993;18:47-53.
17. Peters M, Wellek S, Dienes HP, Junginger T, Meyer J, Meyer Zum Buschendfelde KH, et al. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C. Z Gastroenterol. 1994;32:146-51.
18. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology. 1995;21:650-5.
19. Colombo M. Hepatocellular carcinoma: an overview. In: Rizzeto M, Purcell RH, Gerin JL, Verme G, eds. Viral Hepatitis and Liver Disease. New York: Springer-Verlag: 1994;479-83.
20. Tsai SL, Liaw YF. Etiology and pathogenesis of hepatocellular carcinoma. Dig Surg. 1995;12:7-15.
21. Okuda K. Hepatocellular carcinoma: recent progress. Hepatology. 1992;15: 948-63.
22. Matsubara K, Tokino T. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis. Mol Biol Med. 1990;7:243-60.
23. Hino O, Nomura K, Ohtake K, Kawaguchi T, Sugano H, Kitagawa T. Instability of integrated hepatitis B virus DNA with inverted repeat structure in a transgenic mouse. Cancer Genet Cytogenet. 1989;37:273-8.
24. Kobayashi S, Hayashi H, Itoh Y, Asano T, Isono K. Detection of minus-strand hepatitis C virus RNA in tumor tissues of hepatocellular carcinoma. Cancer. 1994;73:48-52.
25. Ruster B, Zeuzem S, Roth WK. Hepatitis C virus sequences encoding truncated core proteins detected in a hepatocellular carcinoma. Biochem Biophys Res Commun. 1996;219:911-5.
26. Sakamuro D, Furukawa T, Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol. 1995;96:3893-6.
27. Kew MC. Hepatitis C virus and hepatocellular carcinoma. FEMS Microbiol Rev. 1994;14:211-9.
28. Kaklamani E, Trichopoulous D, Tzonou A, Zavitsanos X, Koumantaki Y, Hatzakis A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA. 1991;265:1974-6.
29. Tsai JF, Jeng JE, Ho MS, Chang WY, Hsieh MY, Lin ZY, et al. Effect of hepatitis C and B virus infection on risk of hepatocellular carcinoma: a prospective study. Br J Cancer. 1997;76:968-74.
30. Terada T, Terasaki S, Nakanuma Y. A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy. Cancer. 1993;72:1551-6.
31. Hytiroglou P, Theise ND, Schwartz M, Mor E, Miller C, Thung SN. Macroregenerative nodules in a series of adult cirrhotic liver explants: issues of classification and nomenclature. Hepatology. 1995;21:703-8.
32. Theise ND, Schwartz M, Miller C, Thung SN. Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis. Hepatology. 1992;16:949-55.
33. Takenaka K, Kanematsu T, Fukuzawa K, Sugimachi K. Can hepatic failure after surgery for hepatocellular carcinoma in cirrhotic patients be prevented? World J Surg. 1990;14:123-7.
34. Que FG, Nagorney DM. Hepatocellular carcinoma: a western perspective. Dig Surg. 1995;12:45-52.
35. Kawasaki S, Makuuchi M, Miyagawa S. Resection of hepatocellular carcinoma associated with cirrhosis. Dig Surg. 1995;12:40-4.
36. Kinami Y, Takashima S, Miyazaki I. Hepatic resection for hepatocellular carcinoma associated with liver cirrhosis. World J Surg. 1986;10:294-301.
37. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018-22.
38. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis. Ann Surg. 1991;214:114-7.
39. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg. 1991;15:270-85.
40. Yamasaki S, Makuuchi M, Hasegawa H. Results of hepatectomy for hepatocellular carcinoma at the National Cancer Center Hospital. HPB Surg. 1991;3:235-49.
41. Suenaga M, Nakao A, Harada A, Nonami T, Okada Y, Sugiura H, et al. Hepatic resection for hepatocellular carcinoma. World J Surg. 1992;16:97-104.
42. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993;218:145-51.
43. Gozzetti G, Mazziotti A, Grazi GL, Jovine E, Gallucci A, Morganti M, et al. Surgical experience with 168 primary liver cell carcinomas treated with hepatic resection. J Surg Oncol Suppl. 1993;3:59-61.
44. Segawa T, Tsuchiya R, Furui J, Izawa K, Tsunoda T, Kanematsu T. Operative results in 143 patients with hepatocellular carcinoma. World J Surg. 1993;17:663-7.
45. Tang ZY, Yu YQ, Zhou XD. Evolution of surgery in the treatment of hepatocellular carcinoma from the 1950s to the 1990s. Semin Surg Oncol. 1993;9:293-7.
46. Nagasue N, Kohno H, Chang YC, Taniura H, Yamanoi A, Uchida M, et al. Liver resection for hepatocellular carcinoma. Results of 229 consecutive patients during 11 years. Ann Surg. 1993;217:375-84.
47. Kakazu T, Makuuchi M, Kawasaki S, Miyagawa S, Hashikura Y, Kosuge T, et al. Repeat hepatic resection for recurrent hepatocellular carcinoma. Hepatogastroenterology. 1993;40:337-41.
48. Nagashima I, Hamada C, Naruse K, Osada T, Nagao T, Kawano N, et al. Surgical resection for small hepatocellular carcinoma. Surgery. 1996;119: 40-5.
49. Takenaka K, Kawahara N, Yamamoto K, Kajiyama K, Maeda T. Itasaka H, et al. Results of 280 liver resections for hepatocellular carcinoma. Arch Surg. 1996;131:71-6.
50. Tani M, Edamoto Y, Kawai S, Kobori O, Hayashi S, Hanada K. Results of 90 consecutive hepatectomies for hepatocellular carcinoma: a multivariate analysis of survival. Semin Oncol. 1997;24(2 Suppl 6):S6-1-6.
51. Nagao T, Inoue S, Goto S, Mizuta T, Omori Y, Kawano N, et al. Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis. Ann Surg. 1987;205:33-40.
52. Ikeda K, Saitoh S, Tsubota A, Arase Y, Chayama K, Kumada H, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer. 1993;71:19-25.
53. Pichlmayr R, Weimann A, Ringe B. Indications for liver transplantation in hepatobiliary malignancy. Hepatology. 1994;20(1 pt 2):33S-40S.
54. Schwartz ME, Sung M, Mor E, Fisher A, Popesco I, Fiel I, et al. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg. 1995;180:596-603.
55. Bhattacharya S, Dhillon AP, Rees J, Savage K, Saada J, Burroughs A, et al. Small hepatocellular carcinomas in cirrhotic explant livers: identification by macroscopic examination and lipiodol localization. Hepatology. 1997;25: 613-8.
56. Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K, et al. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology. 1995;22: 20-4.
57. Horiguchi Y, Sekoguchi B, Imai H, Suzuki T, Kubo H, Itoh H, et al. Treatment of choice for unresectable small liver cancer: percutaneous ethanol injection therapy or transarterial chemoembolization therapy. Cancer Chemother Pharmacol. 1994;33(Suppl):S111-4.
58. Livraghi T, Salmi A, Bolondi L, Marin G, Arienti V, Monti F, et al. Small hepatocellular carcinoma: percutaneous alcohol injection - results in 23 patients. Radiology. 1988;168:313-7.
59. Ebara M, Ohto M, Sugiura N, Kita K, Yoshikawa M, Okuda K, et al. Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients. J Gastroenterol Hepatol. 1990;5:616-26.
60. Castells A, Bruix J, Bru C, Fuster J, Vilana R, Navasa M, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology. 1993;18:1121-6.
61. Bruix J. Treatment of hepatocellular carcinoma. Hepatology. 1997;25:259-62.
62. Nerenstone S, Friedman M. Medical treatment of hepatocellular carcinoma. Gastroenterol Clin North Am. 1987;16:603-12.
63. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire. N Engl J Med. 1995;332:1256-61.
64. Bismuth H, Morino M, Sherlock D, Castaing D, Miglietta C, Cauquil P, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg. 1992;163:387-94.
65. Venook AP, Stagg RJ, Lewis BJ, Chase JL, Ring EJ, Maroney TP, et al. Chemoembolization for hepatocellular carcinoma. J Clin Oncol. 1990;8:1108-14.
66. Tanaka K, Nakamura S, Numata K, Okazaki H, Endo O, Inoue S, et al. Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization. Radiology. 1992;185:457-60.
67. Monden M, Sakon M, Gotoh M, Kanai T, Umeshita K, Wang KS, et al. Selection of therapeutic modalities for hepatocellular carcinoma in patients with multiplehepatic lesions. Cancer Chemother Pharmacol. 1992;31(Suppl 1):S38-44.
68. Kenji J, Hyodo I, Tanimizu M, Tanada M, Nishikawa Y, Hosokawa Y, et al. Total necrosis of hepatocellular carcinoma with a combination therapy of arterial infusion of chemotherapeutic lipiodol and transcatheter arterial embolization: report of 14 cases. Semin Oncol. 1997;24(2 Suppl 6):S6-71-80.
69. Nakamura S, Tanaka K. Combination of transcatheter arterial embolization and percutaneous ethanol injection for hepatocellular carcinoma: comparison of efficacies of doxorubicin and epirubicin in transcatheter arterial embolization. Semim Oncol. 1997;24(2 Suppl 6):S6-46-9.
70. Yamamoto K, Masuzawa M, Kato M, Kurosawa K, Kaneko A, Ishida H, et al. Evaluation of combined therapy with chemoembolization and ethanol injection for advanced hepatocellular carcinoma. Semin Oncol. 1997; 24(2 Suppl 6):S6-50-5.
71. Olthoff KM, Millis JM, Rosove MH, Goldstein LI, Ramming KP, Busuttil RW. Is liver transplantation justified for the treatment of hepatic malignancies? Arch Surg. 1990;125:1261-6.
72. Pichlmayr R, Weimann A, Steinhoff G, Ringe B. Liver transplantation for hepatocellular carcinoma: clinical results and future aspects. Cancer Chemother Pharmacol. 1992;31(Suppl):S157-61.
73. Haug CE, Jenkins RL, Rohrer RJ, Auchincloss H, Delmonico FL, Freeman RB, et al. Liver transplantation for primary hepatic cancer. Transplantation. 1992;53:376-82.
74. Iwatsuki S, Starzl TE. Role of liver transplantation in the treatment of hepatocellular carcinoma. Semin Surg Oncol. 1993;9:337-40.
75. Chung SW, Toth JL, Rezieg M, Cameron R, Taylor BR, Greig PD, et al. Liver transplantation for hepatocellular carcinoma. Am J Surg. 1994;167:317-21.
76. Figueras J. Garcia-Valdecasas JC, Rafecas A, Grande L, Virgili J, Fuster JM, et al. Prognosis of hepatocarcinoma in liver transplantation in cirrhotic patients. Transplant Proc. 1997;29:495.
77. Penn I. Hepatic transplantation for primary and metastatic cancers of the liver. Surgery. 1991;110:726-34.
78. Otto G, Heuschen U, Hofmann WJ, Krumm HG, Hinz U, Herfarth C. Is transplantation really superior to resection in the treatment of small hepatocellular carcinoma? Transplant Proc. 1997;29:489-91.
79. Romani F, Belli LS, Rondinara SF, De Carlis L, Rimoldi P, Riolo F, et al. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver. J Am Coll Surg. 1994;178:379-84.
80. Bismuth H, Adam R, Raccuia J, Kalil A. Liver transplantation for hepatocellular carcinoma in cirrhosis. Transplant Rev. 1996;10:13-23.
81. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med. 1996;334:693-9.
82. Colella G, De Carlis L, Rondinara GF, Sansalone CV, Belli LS, Aseni P, et al. Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation? Transplant Proc. 1997;29:492-4.
83. Shijo H, Okazaki M, Koganemaru F, Higashi M, Sakaguchi S, Okumura M. Influence of hepatitis B virus infection and age on mode of growth of hepatocellular carcinoma. Cancer. 1991;67:2626-32.
84. Mazzaferro V, Rondinara GF, Rossi G, Regalia E, De Carlis L, Caccamo L, et al. Milan multicenter experience in liver transplantation for hepatocellular carcinoma. Transplant Proc. 1994;26:3557-60.
85. Annual Report of the U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network. Bethesda, MD: US Dept of Health and Human Services, Public Health Service, Bureau of Health Resources Development, Division of Organ Transplantation; 1997.
86. Nagasue N, Galizia G, Kohno H, Chang YC, Hayashi T, Yamanoi A, et al. Adverse effects of preoperative hepatic artery chemoembolization for resectable hepatocellular carcinoma: a retrospective comparison of 138 liver resections. Surgery. 1989;106:81-6.
87. Carr BI, Selby R, Madariaga J, Iwatsuki S, Starzl TE. Prolonged survival after liver transplantation and cancer chemotherapy for advanced-stage hepatocellular carcinoma. Transplant Proc. 1993;25:1128-9.
88. Stone MJ, Klintmalm GB, Polter O, Husberg BS, Mennel RG, Ramsay MA, et al. Neoadjuvant chemotherapy and liver transplantation for hepatocellular carcinoma: a pilot study in 20 patients. Gastroenterology. 1993;104: 196-202.
89. Olthoff KM, Rosove MH, Shackleton CR, Imagawa DK, Farmer DG, Northcross P, et al. Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg. 1995;221:734-41.
90. Marcos-Alvarez A, Jenkins RL, Washburn WK, Lewis WD, Stuart KE, Gordon FD, et al. Multimodality treatment of hepatocellular carcinoma in a hepatobiliary specialty center. Arch Surg. 1996;131:292-8.
91. Cherqui D, Piedbois P, Pierga JY, Duvoux C, Vavasseur D, Tran Van-Nhieu J, et al. Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot study. Cancer. 1994;73:2721-6.
92. Schwartz M, Sung M, Emre S, Guy S, Sheiner P, Likholatnikov D, et al. Liver transplantation for hepatocellular carcinoma >5 cm diameter: results of a multimodality protocol [Abstract]. In: Abstracts of the 23rd Annual Meeting of the American Society of Transplant Surgeons, Chicago, May 1997. Washington, DC: American Society of Transplant Surgeons; 1997.
93. Hillaire S, Barbu V, Boucher E, Moukhtar M, Poupon R. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma. Gastroenterology. 1994;106:239-42.
94. Matsumura M, Niwa Y, Kato N, Komatsu Y, Shiina S, Kawabe T, et al. Detection of alpha-fetoprotein mRNA, an indicator of hematogenous spreading hepatocellular carcinoma, in the circulation: a possible predictor of metastatic hepatocellular carcinoma. Hepatology, 1994;20:1418-25.